Kidney Cancer Trial, Recruiting NCT06868186 Sponsor: Hutom Corp Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06868186
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a kidney tumor and are scheduled to have a robot-assisted surgery that removes only part of the kidney (not the whole kidney)
  • Your kidney tumor measures 7 centimeters (about 2.75 inches) or smaller
  • You are between 19 and 80 years old
  • You are willing to voluntarily sign a consent form after having the trial fully explained to you in a private setting

Who may not be able to join:

  • You only have one functioning kidney, or your kidneys are fused together (a condition called horseshoe kidney)
  • You are having both kidneys removed
  • You are having a different type of kidney surgery rather than removal of just part of the kidney
  • You have had previous abdominal surgery that is expected to have caused significant internal scarring that could affect the outcome of this surgery
  • You have severe long-term kidney disease, based on a specific kidney function test result (confirm with trial site)
  • Your overall health before anaesthesia is rated as very poor or critically ill, based on a standard medical classification system (confirm with trial site)
  • You have a history of a psychiatric condition or alcohol misuse, or are not expected to be able to follow the trial schedule
  • You have taken part in another clinical trial within the last 4 weeks before screening
  • The trial doctors consider you unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cheryn Song, M.D.,Ph.D., Asan Medical Center

Phone: 82-2-3010-5992

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hutom Corp
Registry
ClinicalTrials.gov
Start date
29 April 2025
Est. completion
29 August 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Operative time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov